
Dr Guofen Yan Considers Strategies for Improving CKD Outcomes in Minority Populations
Slowing progression of chronic kidney disease can help mitigate adverse outcomes in minority populations, said Guofen Yan, PhD, associate professor of biostatistics in the Department of Public Health Sciences at the University of Virginia School of Medicine.
Slowing progression of chronic kidney disease can help mitigate adverse outcomes in minority populations, said Guofen Yan, PhD, associate professor of biostatistics in the Department of Public Health Sciences at the University of Virginia School of Medicine.
Transcript:
Which strategies could be implemented to improve clinical outcomes in Black and Hispanic individuals with chronic kidney disease (CKD)?
Now, that's very interesting because previously we knew of high incidence of kidney failure among minority groups. It has been documented well. But now we know the reason. The reason driving this high incidence is due to the
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.